Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1995-06-06
1997-06-10
Pak, John
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
4241951, 424600, 424601, 424617, 424639, 424641, 424646, 424656, 424678, 424682, 424702, 514 2, 514 7, 514 12, 514 23, 514 24, 514 25, 514 42, 514 53, 514 54, 514 62, 514184, 514332, 514355, 514356, 514387, 514458, 514474, 514492, 514494, 514502, 514505, 514547, 514554, 514556, 514557, 514558, 514560, 514561, 514562, 514574, 514655, 514725, 514763, 514904, 514905, A61K 3119, A61K 31195, A61K 3123, A61K 3128, A61K 3306, A61K 3324, A61K 3800, A61K 3802
Patent
active
056373244
ABSTRACT:
A medical food having the below listed components is administered for several days as the sole source or as a substantial source of the daily caloric intake of a patient suffering from metabolic poisoning: 45 to 65% protein concentrate; 2.5 to 17.5% of grain syrup solids containing 50% dextran; 2.5 to 17.5% of grain syrup solids containing 50% of maltose; 3 to 12% of oil containing 20% of oleic acid, 1 to 11% medium chain triglycerides; magnesium ions; buffering agent; soluble calcium salt; ascorbic acid; 0.40 to 0.65% of .beta. carotene; D-.alpha.-tocopherol; chromium ions in the trivalent or hexavalent form, 0.008 to 0.022% glutathione, 0.08 to 0.22% N-acetylcysteine; L-lysine hydrochloride; 0.08 to 0.22% L-threonine, and 0.08 to 0.22% of L-cysteine.
REFERENCES:
patent: 2283817 (1942-05-01), Martin et al.
patent: 3697287 (1972-10-01), Winitz
patent: 3925568 (1975-12-01), Rao et al.
patent: 3952115 (1976-04-01), Damico et al.
patent: 4009265 (1977-02-01), Howard
patent: 4112123 (1978-09-01), Roberts
patent: 4582705 (1986-04-01), Primes et al.
patent: 4582801 (1986-04-01), Hamada et al.
patent: 4619831 (1986-10-01), Sharma
patent: 4639420 (1987-01-01), Schaffner
patent: 4849225 (1989-07-01), Mitsuhashi et al.
patent: 4876096 (1989-10-01), Mictchell et al.
patent: 5132113 (1992-07-01), Luca
patent: 5358933 (1994-10-01), Porro
patent: 5587399 (1996-12-01), Acosta et al.
I.M. Cox, et al., The Lancet, "Red Blood Cell Magnesium and Chronic Fatigue", vol. 337, Mar. 30, 1991, pp. 757-760, (p. 757 only).
Adrian Hunnisett, et al., Journal of Nutritional Medicine, "Gut Fermentation (or the `Auto-brewery`) Syndrome: a New Clinical Test with Initial Observations and Discussion of Clinical Test with Initial Observations and Discussion of Clinical and Biochemical Implications", 1990, pp. 33-38, (p. 33 only).
H. Malchow, et al., "Feasibility and Effectiveness of a Defined-Formula Diet Regimen in Treating Active Crohn's Disease", one page, (No Date Available).
Don M. Tucker, et al., Am. J. Clin. Nutr., "Nutrition Status and Brain Function in Aging.sup.1,2 ", 1990, vol. 52, pp. 93-102, (p. 93 only).
Jens Kjeldsen-Kragh, et al., The Lancet, "Controlled Trial of Fasting and One-Year Vegetarian Diet in Rheumatoid Arthritis", 1991, vol. 338, No. 8772, pp. 899-902, (first page only).
Frank Edward Allen, The Wall Street Journal, "Lonely Crusade: One Man's Suffering Spurs Doctors to Probe Pesticide-Drug Link", Monday, Oct. 14, 1991, Page one and p. A4, col. 1.
Smith Kline & French, Product Information, "Tagamet", pp. 2120, 2121, (No Publication Date Available).
Kaye H. Kilburn, M.D., "Neurobehavioral Dysfunction in Firemen Exposed to Polychlorinated Biphenyls (PCBs): Possible Improvement after Detoxification", Nov./Dec. 1989, vol. 44, No. 6, p. 345 (first page only).
John T. Sword, et al., American Institute of Nutrition, "Endotoxin and Lipid Peroxidation In Vivo in Selenium- and Vitamin E-Deficient and -Adequate Rats.sup.1,2 ", 1991, p. 251 only.
A.D. Thomson, FRCP(ed). Ph.d , et al., Am J Clin Nutr, "Possible Role of Toxins In Nutritional Deficiency.sup.1 " 1987, vol. 45, pp. 1351-1360 (p. 1351 only).
Brian Ketterer, et al., Environmental Health Perspectives, "The Role of Glutathione in Detoxication", 1983, vol. 49, pp. 59-69 (first page only).
Compendium of Drug Therapy, New York, Biomedical Information Corp., 1983, pp. 47:50-47:72.
Martindale THE Extra Pharmacopoeia, 28th ed. London, The Pharmaceutical Press, 1982, pp. 47-48.
Remington's Pharmaceutical Sciences, 16th ed. Easton (PA), Mack Publishing Co., 1980, pp. 945-947, 970-971, 973-975, and 803.
The Merek Index, 10th edition, Rahway (NJ), Merk & Co., Inc. 1983, p. 1197.
LandOfFree
Medical food composition for metabolic detoxification does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical food composition for metabolic detoxification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical food composition for metabolic detoxification will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-763049